News | April 13, 2011

2011 Heart Failure Programs Staffing Survey Results Released

April 13, 2011 – The American College of Cardiology Foundation (ACCF), American Heart Association (AHA) and the Heart Failure Society of America (HFSA) have released results of a recent survey to determine the current staffing environment of heart failure (HF) clinics and offices focused on heart transplants.

Historically, there have been no published recommendations about the staffing needs for health centers that focus on either HF and/or heart transplant. The goal of the online, jointly-sponsored survey was to understand the current staffing environments of HF, transplant and mechanical circulatory support device (MCSD) programs in the United States and abroad. The survey was conducted among the memberships of the three organizations who had identified themselves as interested in HF, heart transplant or both.

“Heart failure and transplant/VAD (ventricular assist device) programs around the country and the world are struggling to find the right mix of clinicians and other health professionals to manage this increasing population of patients with heart failure,” said Mariell Jessup, M.D., professor of medicine at the University of Pennsylvania, associate chief – clinical affairs, cardiovascular division of medicine, medical director of the Heart and Vascular Center at Penn Medicine, and lead author of the report. “There is likewise an increased scrutiny of heart failure care, policies and quality in the United States. Thus, there are many questions and concerns about the types of clinicians needed to deliver cost-effective and optimal care.”

According to Jessup, this is the first survey of its kind, to the three organizations’ collective knowledge, and was created to answer questions about appropriate staff numbers for heart failure and transplant programs.

Among the key findings of the survey was the conclusion that staff ratios of physicians, nurses and advanced nurse practitioners stayed the same as programs grew in size. This indicated that the healthcare professionals who provide the highly skilled, specialized and time-consuming care to this population are under constant and intense scrutiny trying to meet quality improvement initiatives and with reduced financial resources. Other survey findings concluded that more VADs are currently being done than heart transplants and the majority of programs currently in place had relatively small staffs.

“This survey attempted to understand what the current staffing levels of such programs are and what the numbers of patients cared for by these staff were,” said Jessup. As a result, she and her colleagues believe that the results can be viewed as the first step towards establishing standards for staff ratios.

The report will be published in the May 17, 2011, issue of the Journal of the American College of Cardiology, as well as Circulation: Journal of the American Heart Association and the May 2011 issue of the Journal of Cardiac Failure.

For more information: http://cardiosource.org/ACC

Related Content

Medtronic HeartWare HVAD System Approved for Destination Therapy
Technology | Ventricular Assist Devices (VAD) | October 04, 2017
October 4, 2017 — Medtronic received U.S.
Abiomed Receives FDA PMA Approval for Impella RP for Right Heart Failure
Technology | Ventricular Assist Devices (VAD) | September 28, 2017
Abiomed Inc. recently received U.S. Food and Drug Administration (FDA) pre-market approval (PMA) for the Impella RP ...
Abbott Receives FDA Approval for HeartMate 3 Left Ventricular Assist System
Technology | Ventricular Assist Devices (VAD) | August 29, 2017
Abbott announced it has received U.S. Food and Drug Administration (FDA) approval for its Full MagLev HeartMate 3 Left...
Pre-PCI Impella 2.5 Insertion Improves Survival in Left Main Coronary Artery Heart Attacks
News | Ventricular Assist Devices (VAD) | June 30, 2017
Abiomed Inc. announced the recent publication of a peer-reviewed retrospective study on hemodynamic support with the...
Heartware HVAD recall for its ventricular assist device from Medtronic
Feature | Ventricular Assist Devices (VAD) | May 05, 2017
May 5, 2017 — Medtronic Mechanical Circulatory Support is expanding its recall of its HeartWare Ventricular Assist De
Videos | Ventricular Assist Devices (VAD) | April 14, 2017
A discussion with William O'Neill, M.D., FACC, FSCAI, medical director of the Center for Structural Heart Disease at
Henry Ford Hospital, Detroit Cardiogenic Shock Initiative, Impella pump, ACC.17 clinical study
News | Ventricular Assist Devices (VAD) | April 03, 2017
Hospitals can dramatically increase heart attack survival rates in patients suffering cardiogenic shock by providing...
Metro Detroit cardiologists, increased heart attack survival rate, Impella heart pump, Detroit Cardiogenic Shock Initiative
News | Ventricular Assist Devices (VAD) | March 09, 2017
Metro Detroit cardiologists from five health systems have joined together to increase residents’ survival rate from...
Impella 2.5 heart pump, high-risk PCI, HRPCI, acute kidney injury risk, AKI, Circulation Research study, Abiomed
News | Ventricular Assist Devices (VAD) | March 09, 2017
A new study published in Circulation Research finds use of hemodynamic support with the Impella 2.5 heart pump during...
James Ward, LVAD surgery, left ventricular assist device, UAB, University of Alabama at Birmingham
News | Ventricular Assist Devices (VAD) | March 08, 2017
Congestive heart failure patients at the University of Alabama at Birmingham (UAB) now have reason for optimism with a...
Overlay Init